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Review Articles
The Impact of Caffeine on the Behavioral Effects
of Ethanol Related to Abuse and Addiction:
A Review of Animal Studies
Laura Lo´pez-Cruz,1 John D. Salamone,2 and Merce` Correa1,2
The impact of caffeine on the behavioral effects of ethanol, including ethanol consumption and abuse, has become
a topic of great interest due to the rise in popularity of the so-called energy drinks. Energy drinks high in caffeine
are frequently taken in combination with ethanol under the popular belief that caffeine can offset some of the
intoxicating effects of ethanol. However, scientific research has not universally supported the idea that caffeine
can reduce the effects of ethanol in humans or in rodents, and the mechanisms mediating the caffeine–ethanol
interactions are not well understood. Caffeine and ethanol have a common biological substrate; both act on neuro-
chemical processes related to the neuromodulator adenosine. Caffeine acts as a nonselective adenosine A1 and
A2A receptor antagonist, while ethanol has been demonstrated to increase the basal adenosinergic tone via mul-
tiple mechanisms. Since adenosine transmission modulates multiple behavioral processes, the interaction of both
drugs can regulate a wide range of effects related to alcohol consumption and the development of ethanol addic-
tion. In the present review, we discuss the relatively small number of animal studies that have assessed the inter-
actions between caffeine and ethanol, as well as the interactions between ethanol and subtype-selective adenosine
receptor antagonists, to understand the basic findings and determine the possible mechanisms of action under-
lying the caffeine–ethanol interactions.
Caffeine as a Modulator of Ethanol Abuse
Caffeine and ethanol are widely consumed recreationaldrugs.1,2 Alcohol abuse is a worldwide health problem,
with serious medical, economic, and social consequences.3,4
On the other hand, caffeine intake, even in excess, appears
to be relatively well accepted, because methylxanthines
have activating and attention-preserving properties that can
help productivity and enhance the performance. Interest
in caffeine has grown ever since the introduction to the
market of the so-called energy drinks, which contain caffeine
and related substances in quite high concentrations. These
drinks are being increasingly consumed, often in combina-
tion with substances that have abuse potential.5 In addition,
research with animals has demonstrated the ability of meth-
ylxanthines, and in particular caffeine, to modulate the
psychopharmacological effects of drugs of abuse such as
methamphetamine,6 amphetamine,7 nicotine,8,9 cocaine,10
and ethanol.11 The reasons for combining caffeine with etha-
nol may stem from the popular belief that caffeine can antag-
onize the intoxicating effects of alcohol.12 Some studies have
supported this hypothesis, demonstrating that caffeine atten-
uates ethanol-induced changes in psychological parameters
in humans such as information processing, memory, psycho-
motor performance, and others (for a review13).
Caffeine has been shown to indirectly modulate the activ-
ity of many neurotransmitters and neuromodulators, includ-
ing dopamine, acetylcholine, or glutamate14–17 in various
brain areas. However, in terms of direct actions, caffeine is
most widely described as an adenosine receptor antagonist
that is nonselective for the A1 and A2A subtypes of adenosine
receptors in the central nervous system.1,17–19 Several articles
have demonstrated that there are interactions between aden-
osine and ethanol. Ethanol can increase extracellular adeno-
sine levels by increasing adenosine release,20,21 and by
decreasing adenosine uptake22 that takes place via a facilita-
tive nucleoside transporter.23,24 Inhibition of this transporter
in the presence of ethanol would lead to an increase in the ex-
tracellular adenosine and could therebymodulate some of the
effects of ethanol.21 Secondarily, ethanol increases the adeno-
sine levels because acetate generated by ethanol metabolism
promotes adenosine synthesis25 (see Fig. 1).
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In contrast to the studies showing that caffeine can blunt the
effects of ethanol, there also is evidence that fails to support the
idea of an antagonistic behavioral interaction between caffeine
and ethanol, either in humans26,27 (for review13) or in ro-
dents.28–30 A considerable number of studies employing exper-
imental animal models have been performed to elucidate the
impact of caffeine on the effects of ethanol and on ethanol con-
sumption. In the present review, we have emphasized those
studies addressing behaviors that can be relevant for the devel-
opment of alcohol consumption, abuse, and addiction as a
compulsive habit, as well as studies that evaluate signs of de-
pendence after withdrawal, such as physical abstinence and
craving, which are factors that can lead to relapse.
Drug addictions, including alcoholism, can be conceptual-
ized as disorders of motivation characterized by an excessive
control of the drug over behavior.31–33 This disorder involves
a reorganization of the preference structure of the person,
dramatic changes in the allocation of behavioral resources
toward the addictive substance,34,35 and alterations in the
elasticity of demand for the drug.36 Typically, there is a
heightened tendency to engage in drug-reinforced instrumen-
tal behavior and drug consumption, often at the expense of
other behavioral activities. Addicts will go to great lengths
to obtain the drug, overcoming numerous obstacles and con-
straints. In addition, the development of addiction is attrib-
uted to a profound sensitization in the neural processes that
mediate the drug-seeking behavior, which can facilitate the
incentive properties of drugs and drug-related stimuli as
the addiction process proceeds.37,38 Thus, as addiction pro-
gresses, the drug itself, as well as drug-associated stimuli,
trigger an automatic seeking response that ultimately re-
solves in the consumption of the drug. This automatism has
compulsive characteristics that are devoid of instrumental
feedback, leading to the formation of drug-related habits.39,40
Thus, addiction is a very complex set of behavioral and phys-
iological processes that range all the way from drug con-
sumption, to tolerance for some effects, sensitization of
motor activity, establishment of implicit and explicit learning,
initial sensitivity to reward and punishment, attention shifts,
responsivity to Pavlovian cues, and other processes.
In the present review, studies addressing the impact of
caffeine on some of those behaviors modulated by ethanol
will be summarized. Because of the opposing actions of etha-
nol and caffeine on the adenosine system, studies focusing
on the effects of selective adenosine receptor agonists and an-
tagonists and their interaction with ethanol will be also pre-
sented in an attempt to shed light upon the potential
receptor mechanisms involved.
Caffeine–Ethanol Interactions: Effects on Locomotion
The behavioral stimulant or suppressant actions of drugs
are frequently evaluated by analyzing the locomotor activity
of animals.41,42 Although ethanol is generally classed as a sed-
ative hypnotic and caffeine is considered to be a minor stim-
ulant, both drugs are able to stimulate the locomotor activity
in rodents at some dose,43–48 typically with bell-shaped (or
inverted-U) dose–response functions. Rodents (more in
mice than rats) show a time- and dose-dependent locomotor
response to acute ethanol administration, with low doses
stimulating and high doses reducing locomotion.46,49–52
Methylxanthines such as caffeine also can affect locomotor ac-
tivity in a biphasic way.53–56 However, few studies have eval-
uated the caffeine–ethanol interactions using locomotion as a
measure.51,53,57,58 Waldeck51 evaluated the effect of ethanol
(1, 3, or 4 g/kg, intraperitoneal [IP]) and caffeine (25, 50, or
100mg/kg, IP) on locomotor activity in female mice, and ob-
served that a moderate dose of caffeine (25mg/kg) that stim-
ulated locomotion also potentiated the stimulation induced
by ethanol administered at the lowest dose (1 g/kg), although
it abolished the stimulant effect of a higher dose of ethanol
(3 g/kg). On the other hand, a motor-suppressant dose of caf-
feine (100mg/kg) totally blocked the stimulant effect of eth-
anol (1 g/kg). Moreover, the motor-suppressant effect of the
higher dose of ethanol (4 g/kg) was potentiated by all doses
of caffeine employed.51 These results with female mice are
in close agreement with the observations obtained from cats
reported by Pilcher57. This author concluded that ‘‘when
small doses of caffeine and alcohol are combined, the result
is generally a qualitative algebraic summation of both actions,
that is, each drug produces, qualitatively, its ordinary effects.
However, when large doses of the two drugs are combined,
the effects of the stimulant drug tend to be reversed, resulting
in a greater suppression than the suppressant drug alone.’’57
Oral administration of both drugs in mice could be a useful
tool for studying the effects of the ethanol–caffeine inter-
actions, since both drugs are consumed orally in humans.
Indeed, as mentioned above, energy drinks contain high con-
centrations of caffeine, and their consumption in combination
with alcoholic beverages is a common practice among young
people. The popular belief suggests that, in humans, energy
drinks could reduce the intensity of the motor-suppressant
effects of ethanol.26 However, only one study has explored
the effects of ethanol on the stimulant effects of energy
drinks in animal models.59 In this study done in mice, oral
FIG. 1. Schematic showing ethanol regulation of adenosine
production (1), release (2), and uptake (3), as well as caffeine
blockade of adenosine receptors (4) in the central nervous sys-
tem. A1R and A2AR, adenosine A1 and A2A receptors; ADH,
alcohol dehydrogenase; ALDH, aldehyde dehydrogenase;
ATP, adenosine triphosphate; AMP, adenosine monophos-
phate; CAT-H2O2, catalase; CYP-2E1, cytochrome P4502E1;
ENT, equilibrative nucleoside transporters.
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administration of energy drinks did not significantly alter the
effects of moderate oral doses of ethanol (0.5, 1.0, or 1.5 g/
kg), but was able to reduce the suppressant effects of a higher
dose of ethanol (2.5 g/kg). It is possible that in this study, some
effects could be attributed to other stimulant components of
the energy drinks, such as taurine, which has been shown to
interact with ethanol on locomotion.60,61 However, acute oral
coadministration of caffeine at a low dose (10mg/kg) com-
bined with ethanol (1.6, 2.4, and 3.2g/kg) was demonstrated
to increase locomotor activity compared with the effect ob-
served after separate administration of each individual drug.53
It is also relevant to consider the effects of acute adminis-
tration of caffeine or ethanol on the chronic actions of these
substances.58,62–64 Chronic caffeine intake reduces spontane-
ous locomotion in mice62 and rats.58 However, chronic
caffeine consumption (0.1% during 30 days) increased sensi-
tivity (relative to water consumption) to the activating effects
of an acute dose of ethanol (1.5 g/kg, IP) in rats.58 In contrast,
in mice exposed to chronic caffeine (1 g/L during 7 days),
acute doses of ethanol (1.5 and 2.5 g/kg, IP) significantly in-
duced locomotion, but never to the level of animals in the
water control group.62–64 Further, acute caffeine administra-
tion (10–35mg/kg) increased locomotion to a similar extent
in mice chronically consuming ethanol (5%, v/v) and those
in the water control group (in this case, ethanol did not affect
spontaneous locomotion). Thus, chronic consumption of eth-
anol did not change the acute stimulant effects of caffeine.62
The same pattern of results was found after acute administra-
tion of 5¢-N-ethylcarboxamidoadenosine (NECA), an adeno-
sine agonist with high affinity for both the A1 and A2A
adenosine receptors. In this case, NECA suppressed locomo-
tion in a similar manner in mice chronically consuming either
water or ethanol.62
Adolescence is a vulnerable time for organisms exposed to
drugs of abuse such as ethanol.65 It is widely acknowledged
that the human adolescent brain is not fully mature,66,67
and there is evidence from animal studies that exposure to al-
cohol during adolescence can affect subsequent brain/behav-
ior development.68,69 Voluntary consumption of ethanol (at a
concentration of 8.5 g/L that led to a dose of 1.0–1.5 g/kg),
caffeine (at a concentration of 170mg/L that led to a dose
of 20–30mg/kg), or an ethanol–caffeine combination during
late adolescence in male and female rats had effects on the
subsequent adult behavior that were dependent on the sex
of the rats.70 Males showed more ambulation after exposure
to the alcohol–caffeine mixture, while females exposed to
the mixture showed the opposite effects, that is, suppressed
ambulation.70 This pattern of results could be related to sex
differences in the sensitivity to the neurotoxic effects of caf-
feine.71 In hippocampal cultures pre-exposed to 5mM etha-
nol for 10 days, caffeine (5 or 20lM) produced greater
neurotoxicity in cultures from female tissues than from
male ones, specifically in the dentate gyrus and the CA1 re-
gion.71 These results demonstrate the importance of including
both sexes in investigations of this sort.
In summary, the interacting effects of caffeine and ethanol
on locomotor activity are quite complex. It seems that at
low doses, acute caffeine administration can increase the
stimulant effects of acute doses of ethanol. However, when
caffeine or ethanol doses are higher, a potentiation of the sup-
pressant effects of both substances is most evident. On the
other hand, chronic administration of either substance does
not appear to change the acute doses at which locomotion
can be stimulated.
Caffeine–Ethanol Interactions:
Effects on Motor Coordination
At medium-to-high doses, a typical action of ethanol is to
impair motor coordination.72–76 This effect generally shows
tolerance with repeated ethanol exposure.77,78 The develop-
ment of tolerance appears to be relevant for the emergence
of ethanol abuse and dependence, because it can attenuate
the performance impairing the effect of the drug, which pro-
motes the use of escalating doses.79 Several studies have
investigated the ability of caffeine to modulate ethanol-
inducedmotor incoordination and have explored the possible
involvement of adenosine receptors.28,29,76,80–82
A single injection of a broad range of doses of caffeine (5–
75lg) administered in the brain ventricles intracerebroventric-
ular (ICV) or peripherally (2.5–62.5mg/kg, IP) did not alter
motor coordination in mice evaluated in the rotarod test.80,81
However, pretreatment with low doses of caffeine (2.5–25.0lg
ICV, or 2.5–5.0mg/kg IP) was effective in decreasing the degree
and duration of motor incoordination produced by a single
dose of ethanol (2g/kg, IP). The antagonism by caffeine of eth-
anol-induced motor incoordination was dose related, since
higher doses of caffeine (75lg ICV, or 62.5mg/kg IP) enhanced
ethanol-induced motor incoordination.80,81 The methylxanthine
(and caffeine metabolite) theophylline was less potent, but
dose-dependently attenuated (100–150lg, ICV, 50mg/kg
IP) the motor incoordinating effect of acute ethanol (1.5–
2 g/kg, IP).73,74 On the other hand, potentiation of ethanol-
induced ataxia was also observed after pretreatment with an-
other methylxanthine, 3-isobutyl-1-methylxanthine (IBMX).81
Chronic oral administration of caffeine for 10 days (45 and
90mg/kg/day) and IBMX (30 and 60mg/kg/day) potentiates
acute ethanol-induced motor incoordination (1.5 g/kg, IP), an
effect that was associatedwith increased adenosine A1 receptor
binding compared to tap water controls.28 However, no inter-
action with ethanol-induced motor incoordination (1.5g/kg,
IP) was observed after chronic theophylline (75 and 150mg/
kg/day) consumption.28 This lack of effect of chronic theoph-
ylline on motor incoordination induced by ethanol was paral-
leled with the lack of changes in the A1 receptor density.
28
More recently, it has been demonstrated that acute oral co-
administration of caffeine (20mg/kg) and ethanol (2.5 g/kg)
attenuated the ethanol-induced motor impairment in rats
evaluated in the accelerating rotarod.29 This effect was
also observed after acute IP administration of an A1-selective
receptor antagonist (8-cyclopentyl-1,3-dipropylxanthine;
DPCPX) injected after oral ethanol administration, but
not with an A2A selective receptor antagonist 2-(2-Furanyl)-
7-(2-phenylethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]
pyrimidin-5-amine (SCH 58261), suggesting again that A1
adenosine receptors are involved in motor incoordination in-
duced by ethanol.29 However, microinfusions of both the A1
receptor-selective agonist cyclohexyladenosine (CHA) and the
A2A-selective agonist 5¢-N-ethylcarboxamido-2-[2-(4-phenyl-
(3-propanoic acid)] (CGS21680) into the rat motor cortex
significantly accentuated motor incoordination induced by
ethanol (1.5 g/kg IP) in a dose-related manner.76 CHA was
more potent than CGS21680 in producing this effect. How-
ever, the potentiation induced by the A1 and A2A agonists
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was attenuated by the A1-selective antagonist DPCPX,
but not by the A2A receptor-selective antagonist 8-(3-
chlorostyryl)caffeine, further emphasizing the involvement
of the adenosine Al receptor subtype in these effects.
76
The involvement of different adenosine receptors in the
development of rapid tolerance to ethanol-inducedmotor incoor-
dination in mice has also been evaluated.82 A single administra-
tion of caffeine (3, 10, or 30mg/kg, IP) or selective antagonists
of the A1 or A2A receptors did not change the performance of
animals treatedwith ethanol (2.5g/kg) on the first day of testing.
However, caffeine administered on the first day was able to
block the development of tolerance to ethanol that was mani-
fested on the second day. Moreover, caffeine’s blockade of
the rapid tolerance to ethanol-induced incoordination appears
to be mediated by the A1 rather than A2A receptors, because
DPCPX, but not 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-
a][1,3,5]triazin-5-ylamino]ethyl)phenol (ZM241385), also blocked
rapid tolerance. These data are in agreement with previous
studies,29,76 and it is reasonable to suggest that this effect may
be due to the high number of A1 receptors in the areas controlling
motor coordination, such as the cortex and cerebellum.83
To summarize, acute low doses of caffeine can reduce the
incoordination effects of ethanol, but high doses of caffeine
can potentiated them. Moreover, the adenosine A1 receptors
appear to be more important for these effects than the A2A re-
ceptors. The ability of caffeine to attenuate the rapid tolerance
to ethanol-induced incoordination effects also has been attrib-
uted more to the A1 than A2A receptors.
Caffeine–Ethanol Interactions: Sedation and Narcosis
Ethanol intoxication produces sedative and, at high doses,
even hypnotic effects.72,84–86 In contrast, caffeine enhances
wakefulness and alertness, effects that are associated with
its ability to block adenosine receptors.87–91 Although the ef-
fects of ethanol or caffeine on sedation and alertness have
been widely described, their interaction is much less well
characterized, and only a few studies have explored the im-
pact of caffeine on the narcosis or loss of the righting reflex
(LORR) induced by ethanol in rodents.28,92–95
For example, it has been demonstrated in mice that when
coffee (15mg/mL) or caffeine (0.5mg/mL) were orally ad-
ministered before ethanol (75% v/v), the latency to the
LORR increased.92 However, this effect was not observed
when caffeine was administered after ethanol. Moreover,
this effect was not due to pharmacokinetic interference,
since no decrease in plasma ethanol levels was detected in
mice pretreated with coffee or caffeine.92 In another study
in mice, an intermediate dose of caffeine (25mg/kg, IP) ad-
ministered before an IP injection of narcotic doses of ethanol
also blunted the effect of ethanol, in this case by reducing the
duration of the LORR.93 This effect was not seen with higher
doses of caffeine (40–100mg/kg).81,93 Theophylline (50mg/
kg, IP) produced the same pattern of effects, prolonging the
onset and shortening the duration of ethanol-induced
LORR81,73; however, IBMX (12.5mg/kg IP) did not alter the
LORR induced by ethanol.81
Caffeine and theophylline have also been compared in
long-sleep (LS) and short-sleep (SS) mice, which are selec-
tively bred for differences in sensitivity to the LORR induced
by ethanol, but also have differential sensitivity to purinergic
agonists and antagonists.94 LS and SS mice showed differ-
ences in sensitivity to the nonselective adenosine antagonists,
theophylline and caffeine.95 These drugs also produced a
distinct pattern of effects in the two strains of mice; while theo-
phylline reduced the duration of LORR induced by ethanol
in both strains of animals (at a broader range of doses in LS
mice), caffeine only did so in LS mice. Moreover, caffeine at
doses of 10 and 20mg/kg increased the LORR in SS mice.
Theophylline did not change the blood or brain ethanol elim-
ination rate, but the effects of caffeine on blood ethanol levels
were affected.95 The A1 receptor-selective agonists CHA and
l-phenyl isopropyl adenosine (PIA), as well as the nonselec-
tive A1-A2A agonists, 2-chloroadenosine and N-ethylcarboxa-
midoadenosine, increased the LORR in both LS and SS
mice.95 In general, LS mice were more affected than SS mice
by purinergic drugs, suggesting that there may be differences
in the adenosine systems of these lines of mice; this observa-
tion may aid in understanding how they differ in ethanol sen-
sitivity as well.
As discussed above, adenosine is involved in mediating
many of ethanol’s intoxicating effects, such as ataxia74,96,97
and sedation (for review98,99). However, in rodents, adeno-
sine analogs seem to increase LORR only during interactions
with hypnotic drugs, rather than causing a direct deep hyp-
notic effect or unconsciousness.100 Thus, dipyrimadole (30–
40mg/kg IP), an inhibitor of adenosine uptake, increased
the duration of LORR in mice only after the administration
of hypnotic doses of ethanol (3.5–4.0 g/kg, IP).73,93 In regard
to the specific adenosine receptors implicated in the modula-
tion of the hypnotic effects of alcohol, more recent studies
using novel selective A2A antagonists suggest that A2A rather
than A1 receptors seem to mediate this effect. The A2A antag-
onist SCH58261, but not the A1 antagonist DPCPX, blocked
LORR induced by ethanol.93 In addition, female and male
mice lacking the adenosine A2A receptor (i.e., A2A KO mice)
showed a reduced duration of LORR compared to their
wild-type (WT) siblings after ethanol administration.93,101
In summary, adenosine agonists seem to potentiate the
duration of LORR, while adenosine antagonists reduce
the LORR induced by high doses of ethanol. In general, non-
selective adenosine receptor antagonists, as well as selective
A2A antagonism or genetic deletion, reduce ethanol induced
LORR.
Caffeine–Ethanol Interactions: Effects on Learning
and Memory
High doses of ethanol can also cause learning impairments,
amnesia, or impaired retrieval of information, effects that can
persist long after the drug wears off.102–104 Complete or par-
tial memory impairment occurs commonly from the episodes
of binge drinking in both alcoholics and nonalcoholics.105
This memory impairment may reflect a disruption of encod-
ing, storage, consolidation, and/or retrieval capability.106,107
Other studies have shown that moderate doses of ethanol de-
livered after learning generally enhance or have little effect on
memory examined the next day,108,109 and caffeine at moder-
ate doses has been shown to facilitate memory acquisition
and retention in animals assessed on various learning
tasks.110–113
A few articles have focused on the interaction between caf-
feine and ethanol on the memory in rodents.114,115 Ethanol
and caffeine coadministration has demonstrated to be
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neuroprotective in different models of ischemia.114,116,117
Thus, an acute administration of caffeinol (combination of
10mg/kg caffeine plus 0.65 g/kg alcohol, IP) 15 minutes
after traumatic brain injury in rats, produced an improve-
ment in working memory tasks in the Morris water maze,
compared to the vehicle-treated animals.114 This protection
was not due to effects on motor performance.
Retrograde amnesic effects of ethanol, caffeine, or a combi-
nation of both agents have been evaluated in rats with an ol-
factory memory test that uses social odors.115 A high dose of
ethanol (3.0 g/kg, IP) administered after exposure to a novel
odor produced memory recall or retrograde memory impair-
ments the following day, and caffeine (5mg/kg, IP), either 20
minutes before or 1 hour after exposure to the novel odor,
prevented this ethanol disruption in recognition memory.115
In humans, ethanol and caffeine can also produce state-
dependent memory effects.118,119 State-dependent learning
or memory is the term applied to the condition in which a be-
havior that is learned in a drug state is most readily recalled
when the organism is in the same drug state.120 In rodents,
administration of ethanol before training can impair the re-
trieval of tasks learned in a state-dependent manner, which
is reversible by readministering ethanol before the retrieval
test.121,122 This type of study also reflects the ability of ethanol
to serve as an interoceptive cue that can aid learning and per-
formance of a specific operant response.123 Defined in this
way, acute ethanol administration can exert state-dependent
effects on conditioned avoidance responding.124,125 However,
caffeine (100mg/kg, IP) does not change the performance of
rats already trained to discriminate the interoceptive cue
produced by ethanol administration (1.5 g/kg, IP) in an ac-
tive avoidance task performed in a typical three-chamber
apparatus.126
The interaction between caffeine and ethanol also has been
evaluated using the acquisition of an avoidance task per-
formed in a plus-maze discrimination apparatus.127 This ap-
paratus uses an elevated plus-maze consisting of two
opposing open arms and two opposing enclosed arms. Dur-
ing training, animals are free to explore all four arms, but
are conditioned to avoid one of the enclosed arms (the aver-
sive arm) by the presentation of both light and white noise
stimuli when they enter that arm. During the testing session
(24 hours after the training session), animals are free to ex-
plore all four arms again, but no cues are presented. Time
in the aversive arm was used as an index of memory. Ethanol
alone (1.0 and 1.4 g/kg, IP) or in combination with caffeine
(20 and 40mg/kg, IP) administered before the training ses-
sion produced a learning deficit manifested during the test
session. Only the highest dose of caffeine alone (40mg/kg)
produced that effect. However, that was not due to a state-
dependent effect, since the administration of this dose of caf-
feine before the test did not reverse the learning deficit.127
Caffeine also does not change the conditioned avoidance of
a sweet solution produced by ethanol. This conditioned taste
avoidance (CTA) is produced by administering an acute dose
of ethanol after voluntary consumption of saccharine, and is
observed as a reduction in saccharine consumption the fol-
lowing day.30 Caffeine (2.5–10mg/kg, IP) did not block the
association between taste and ethanol effects (1.0–1.5 g/kg,
IP); thus, saccharine consumption was not restored. How-
ever, caffeine by itself was able to produce CTA at a moderate
dose (20mg/kg, IP).30
Taken together, these studies indicate that caffeine appears
to prevent explicit memory deficits induced by high doses of
ethanol, but does not affect the perception of the interoceptive
cue generated by ethanol, and it does not prevent the disrup-
tive effects of ethanol on avoidance learning in discriminative
procedures, suggesting a lack of effect of caffeine on implicit
learning processes regulated by ethanol.
Caffeine–Ethanol Interactions: Effects on Anxiety
and Stress
Considerable evidence indicates that ethanol is capable of
reducing anxiety levels in humans and other animals,128–130
and adenosine has been proposed as a mediator of this anxio-
lytic effect.131–133 In this regard, adenosine itself, as well as aden-
osine receptor agonists, has anxiolytic effects as assessed by a
number of ethological tests in rodent models.134,135 On the
other hand, methylxantines such as caffeine and theophylline
have been demonstrated to increase anxiety in humans136–139
and in rodents in different anxiety paradigms.127,140–143
Caffeine modulation of the effects of ethanol on anxiety has
been explored in a handful of studies,70,127,131 which also
assessed the role of adenosine receptor subtypes in this inter-
action. Thus, caffeine, across a broad range of doses that ex-
tended into the anxiogenic range (10–40mg/kg), was
shown to reduce the anxiolytic-like effect of ethanol (1.0–
1.4 g/kg, IP) in the elevated plus-maze in mice.127,131 The ef-
fects of caffeine on acutely administered ethanol appeared to
be mediated by the A1 adenosine receptors, since the selective
adenosine A1 receptor antagonist DPCPX, but not the A2A
receptor antagonist ZM241385, significantly reduced the an-
xiolytic-like effect of ethanol (1.2 g/kg).131 Moreover, an anxi-
olytic response was observed after coadministration of
nonanxiolytic doses of the A1 adenosine agonist 2-chloro-
N6-cyclopentyladenosine (CCPA) and ethanol.131
A different pattern emerges when these substances are ad-
ministered chronically. The anxiety-related effects of chronic
oral consumption of alcohol (1.0–1.5 g/kg) combined with
oral consumption of caffeine (20–30mg/kg) during adoles-
cence were evaluated in male and female rats when they
reached mid-adulthood.70 Males that had previously con-
sumed alcohol plus caffeine showed anxiolysis in the light
and dark box and in the open field. However, females ex-
posed to the drug mixture showed an anxiogenic-like effect.70
Thus, as described above, the results in females and males
seem to be opposite.
Caffeine and ethanol not only regulate anxiety-like behav-
ior but also regulate the stress responses involving activation
of the hypothalamo–pituitary–adrenal (HPA) axis.143–150
HPA axis activation ultimately leads to increases in the bio-
synthesis and systemic secretion of adrenocorticosteroids.
The effects of alcohol and other drugs of abuse on this axis
are relevant, because a link between the stress response and
drug abuse and addiction has been observed. Stress is one
of the main factors stimulating drug consumption and the re-
lapse to drug taking in abstinent addicts.151,152 Further,
chronic drug exposure affects the brain stress response sys-
tems. Thus, drug abuse is often accompanied by enhanced
brain stress responses, which in turn may contribute to the
addiction process.152
In regard to ethanol and caffeine, moderate acute doses of
ethanol144–147 or caffeine143,148–150 have been shown to
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increase the plasma corticosterone levels in rodents and corti-
sol in humans. However, only one study so far has explored
the interaction of caffeine and ethanol on corticosterone re-
lease.153 In this study, a low dose of caffeine (5mg/kg IP) de-
livered before a low dose of ethanol (0.8 g/kg IP) elevated
plasma corticosterone levels. This increase was not observed
after ethanol or caffeine was administered alone.153
In summary, more studies need to evaluate this complex
interaction, but so far, the evidence suggests that caffeine
and ethanol can counteract each other’s effects on acute anx-
iety levels in rodents, and some of this evidence points to A1
adenosine receptors as being responsible for the anxiolytic ef-
fects of ethanol as well as of the reversal of this effect by caf-
feine. It would be very important to have a clearer view of the
interaction between these substances after chronic consump-
tion, because tension reduction theories suggest that the anxi-
olytic effects of alcohol facilitate alcohol use by anxious
individuals.154,155 Moreover, a growing body of evidence
shows that corticosterone may directly modulate alcohol
drinking.156–159
Effect of Caffeine on Alcohol Self-Administration
Epidemiology studies have shown that a positive correla-
tion may exist between the consumption of caffeine and
that of ethanol.160,161 Moreover, it has been demonstrated
that people who use energy drinks consume alcohol more fre-
quently than people who do not (for review13). Studies in ro-
dents have shown a complex relationship between caffeine
and ethanol intake.11,162–164 Caffeine administered in the
diet of malnourished female rats has been shown to facilitate
voluntary ethanol drinking in a free access two-bottle para-
digm,162,163 and removal of caffeine from the diet restored al-
cohol consumption to baseline levels. This effect was not
taste-related, because quinine did not produce the same pat-
tern as caffeine.163 However, slow-release caffeine pellets
(200mg/day during 21 days) failed to alter ethanol intake
in an unlimited free-choice paradigm in female rats.165 This
lack of effect was specific to caffeine, since slow-release pellets
containing other stimulants did increase ethanol consump-
tion.165 Caffeine administered acutely did not produce a con-
sistent pattern of effects; a low dose of caffeine (5mg/kg, IP)
promoted ethanol drinking in male rats using a limited-access
two-bottle choice paradigm.11 However, a high acute dose of
caffeine (50mg/kg, IP) decreased ethanol as well as food in-
take in deprived male and female rats.166 The lack of caffeine
effects on ethanol intake has been also demonstrated in a re-
cent study.167 The presence of caffeine (1 g/L) in alcoholic so-
lutions (10% v/v) did not increase the ethanol consumption
of male rats exposed to a free-choice procedure during 50
days. Interestingly, it did prevent the alcohol deprivation ef-
fect (ADE), blocking an increase of ethanol intake after an ab-
stinent period of 7 days.167 Because ADE has been suggested
as an animal model of human alcohol craving and relapse,168
the effect of caffeine on such effect is a very relevant finding.
Research on the role of adenosine receptor subtypes in eth-
anol intake has mainly focused on the A2A receptors. Ethanol
intake and preference were increased in male and female
KOA2A mice compared to their WT counterparts in a free-
choice task.101 Results in the same direction have been ob-
served in studies employing pharmacological manipulation
of adenosine transmission. Both acute and subchronic (7
days) IP administration of the A2A receptor antagonist 8-
ethoxy-9-ethyl-9H-purin-6-amine (ANR94) increased the lev-
els of ethanol intake in alcohol-preferring rats assessed in a
free choice task.169 Conversely, a reduction of ethanol intake
was observed after acute IP administration of the A2A recep-
tor agonists CGS21680 and 5¢-N-ethylcarboxamido-2-(2-phe-
nethylthio) (VT7).169
The involvement of adenosine A2A receptors in ethanol
seeking and intake also has been evaluated in operant cham-
bers in which animals have to exert various levels of effort to
have access to ethanol (e.g., lever pressing on fixed ratio [FR]
schedules ranging from FR1 to FR3).169–172 In this case,
the pattern of effects produced by different A2A receptor an-
tagonists was more complex. While SCH58261 reduced the
number of ethanol-reinforced responses and ethanol con-
sumption,172 ANR94 increased responding.169 Moreover,
3,7-dimethyl-1-propargylxanthine had a multiphasic effect
on the number of lever presses and amount of ethanol con-
sumed during operant self-administration.170,171 The A2A ago-
nists CGS21680 and VT7 decreased lever pressing and alcohol
consumption in alcohol-preferring rats tested on an FR1 sched-
ule.169 Using the same behavioral procedure, no effect was ob-
served with an adenosine A1 antagonist DPCPX.
170,172
Taken together, it appears that the results so far are not
conclusive (see summary in Table 1). The specific effects of
adenosine antagonism on ethanol self-administration may
depend on factors such as food restriction, sex, ethanol-intake
or reinforcement paradigms, or other factors. For instance, it
has been suggested that the suppressive effects of caffeine on
ethanol intake seen in some studies could be due to the use of
high toxic doses of caffeine.165,166 However, the fact that
chronic caffeine blocked the ADE effect167 suggests that caf-
feine could be promising as a treatment for protective absti-
nence, although more studies should assess this point.
Effect of Caffeine on Ethanol Withdrawal
Withdrawal is a defining characteristic of drug dependence
and is often characterized by an impaired physiological func-
tion and enhanced negative effect, symptoms strongly associ-
ated with relapse.173 Symptoms of ethanol withdrawal
appear between 12 and 24 hours after the time when ethanol
levels in blood are no longer detectable. For instance, acute
withdrawal appears several hours after a high dose of ethanol
has been administered, and produces a mild set of symptoms
(i.e., hangover) that, among other effects, can include in-
creased anxiety.132 Moreover, the withdrawal syndrome
after chronic administration or chronic consumption of signif-
icant amounts of ethanol is also characterized by an increased
anxiety response (for review174). Other common symptoms of
this syndrome in rodents are marked hyperalgesia,175 trem-
ors, piloerection,176,177 changes in cardiovascular178 and gas-
trointestinal functions,176 seizures, or convulsions,179,180
which correspond to the withdrawal symptoms observed in
humans (for review see174,176).
Although there are no animal studies focusing on the im-
pact of caffeine on anxiety induced by ethanol withdrawal,
other adenosine receptor modulators have been shown to
regulate the signs of ethanol withdrawal. The administration
of adenosine 18 hours after an acute ethanol injection in mice,
which is at the onset of the peak of withdrawal as character-
ized by high levels of anxiety, reduced increases in anxiety
14 LO´PEZ-CRUZ ET AL.
observed in an elevated plus-maze.132 This reversal effect was
also observed after the administration of a selective adenosine
A1 receptor agonist CCPA, but not after a selective adenosine
A2A receptor agonist N
6-[2-(3,5-dimethoxyphenyl)-2-(2-
methylphenyl)ethyl]adenosine.132Moreover, the anxiolytic ef-
fect of CCPA on ethanol withdrawal-induced anxiety was re-
versed by the selective adenosine A1 antagonist DPCPX.
132
The results from studies involving chronic ethanol adminis-
tration appear to be different from those observed after
acute ethanol administration. In this case, the A1 receptor an-
tagonist 8-cyclopentyltheophylline reduced the anxiogenic
effect produced by ethanol withdrawal in the elevated plus-
maze and in the dark/light test in rats.175
Removal of a liquid diet containing ethanol (6.7%, v/v)
after chronic exposure led to handling-induced hyperexcit-
ability, a less-frequently used behavioral measure of with-
drawal.181 Administration of an adenosine A1 receptor
agonist R-PIA and the adenosine A2A receptor agonist
CGS21680 significantly reduced this withdrawal sign, sug-
gesting the involvement of both the A1 and A2A receptors.
181
In this study, there were no changes in the adenosine A1 and
A2A receptors or in adenosine transporter-binding sites in the
frontal cortex and the cerebellum. However, a reduction in
adenosine transporter-binding sites was observed in the stria-
tum of ethanol-withdrawn mice.181
The administration of adenosine, adenosine analogs, or
dipyridamole (an inhibitor of adenosine reuptake) has been
shown to reduce the number of rats in which audiogenic
convulsions appeared during ethanol withdrawal.179 The
adenosine A1 receptor agonist CCPA also produced a dose-
dependent reduction of the convulsions induced by an in-
tense audiogenic stimulus, as well as tremors, which were
apparent 24 hours after repeated high doses of oral ethanol
administration (12–18 g/kg per day) in rats.182 Moreover, ad-
ministration of the adenosine A1 antagonist DPCPX com-
pletely abolished the antagonistic effects of the adenosine
A1 agonist CCPA on both tremors and audiogenic seizures
during ethanol withdrawal.182 The A2A adenosine receptor
also has been implicated in withdrawal-induced convul-
sions.183,184 In fact, these receptors are expressed in areas of
the brain involved in epileptogenesis, including the striatum,
neocortex, and hippocampus.185 A2AR KO mice are less sus-
ceptible to seizures caused by ethanol withdrawal that was in-
duced by the cessation after 10 consecutive days of ethanol
intake (up to 6.3% v/v). This effect has also been observed
when the A2A adenosine receptor antagonist ZM 241385 was
administered during the last 5 of 10 days of ethanol intake.180
Similarly, subchronic coadministration of theophylline (1g/
kg, IP; twice daily) during chronic ethanol intake (6.5% w/v)
was demonstrated to decrease hyperalgesia and withdrawal
scores in rats during ethanol withdrawal.186 However, the
protective effect of A2A receptor antagonism or repeated the-
ophylline administration was not observed after the acute ad-
ministration of caffeine or theophylline (5–25mg/kg, IP); in
this case, there was no effect on the audiogenic seizures ob-
served during ethanol withdrawal in rats.179 However, caffeine
and theophylline did antagonize the suppressive effects of
adenosine analogs on these withdrawal symptoms.179
In summary, adenosine seems to play an important role in
the regulation of ethanol withdrawal. Agonism of the adeno-
sinergic system, especially via stimulation of A1 adenosine re-
ceptors, reduces some of the withdrawal symptoms that
occur after acute or chronic ethanol administration. More im-
portantly, pharmacological antagonism or genetic deletion of
the adenosine A1 and/or A2A receptors could have a role in
prevention of withdrawal during ethanol intake.180,186
Table 1. Summary of the Effects of Pharmacological and Genetic Manipulations of Adenosine Receptors
on Free Ethanol Intake and Operant Self-Administration
Free intake
Drug Mechanism of action Sex/species
Ethanol
concentration Ethanol Intake Refs.
Caffeine Non selective
antagonist A1/A2A
Male and female rats 10% (v/v) Increase 11, 163, 164
Male and female rats 5% (w/v)
10% (v/v)
Decrease 166, 167
Male rats 10% (v/v) No effect 168
ANR94 A2A antagonist Male alcohol-preferring rats 10% (v/v) Increase 170
A2A genetic
deletion
Male and female mice 3%–20% (v/v) Increase 101
CGS 21680 A2A agonist Male alcohol-preferring rats 10% (v/v) Decrease 170
VT7 A2A agonist Male alcohol-preferring rats 10% (v/v) Decrease 170
Operant self-administration
Drug
Mechanism
of action Sex/species
Ethanol
concentration/schedule Ethanol intake Refs.
ANR94 A2A antagonist Male alcohol-preferring rats 10% (v/v), FR1 Increase 170
SCH58261 A2A antagonist Male alcohol-preferring rats 10% (v/v), FR3 Decrease 173
DMPX A2A antagonist Male rats 10% (w/v) FR1 Decrease 172
Male rats 10% (v/v), FR3 Bimodal effect 171
DPCPX A1 antagonist Male alcohol-preferring rats 10% (v/v), FR3 No effect 171, 173
CGS21680 A2A agonist Male alcohol-preferring rats 10% (v/v), FR1 Decrease 170
VT7 A2A agonist Male alcohol-preferring rats 10% (v/v), FR1 Decrease 161
DMPX, 3,7-dimethyl-1-propargylxanthine.
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Nevertheless, most of these studies have employed manipu-
lations affecting specific adenosine receptor subtypes rather
than caffeine itself, and therefore have not directly assessed
the popular belief that a cup of strong coffee can antagonize
some of the symptoms of ethanol withdrawal, especially
after an acute episode of alcohol consumption in nonalcoholic
individuals.
Future Directions
After reviewing the literature on the caffeine–ethanol inter-
actions, one can see that a significant body of work has been
performed. However, a clear pattern of results does not easily
emerge. Further experiments are needed to establish the spe-
cific range of doses, patterns of administration, sex differ-
ences, and other factors that could clarify some of the
apparent contradictions in the results observed in many of
the studies presented above.
More importantly, there is a dearth of studies about the in-
teractions of both agents on processes that are particularly rel-
evant for addiction, such as Pavlovian conditioning, habit
formation, or motor sensitization, which seem to contribute
to the acquisition and intensification of a compulsive drug-
seeking behavior.38,40 Although sensitization of locomotor ac-
tivity by caffeine as well as cross-sensitization with other
drugs such as amphetamine187 and nicotine188 has been ob-
served, so far there are no studies of possible cross-sensitization
between ethanol and caffeine. In fact, preliminary studies
from our laboratory show that caffeine reduces locomotion
in animals repeatedly exposed to a sensitizing dose of eth-
anol.189 Further, the effects of the caffeine–ethanol interac-
tions on learning processes are not well understood, in part
due to the complexity of learning processes per se. Caffeine
has been demonstrated to induce a conditioned place prefer-
ence,190–192 and also to modulate a conditioned place preference
induced by methamphetamine or cocaine.6 It also would be
important to study the effects of caffeine on the acquisition
of Pavlovian cues associated with ethanol in this paradigm.
In summary, despite the fact that this area of inquiry has
grown increasingly important due to the potential dangers
of combining high-caffeine energy drinks with ethanol, ani-
mal researchers have only scratched the surface of this com-
plex and multifaceted field. Additional investigations will
be required to identify how caffeine and ethanol interact to
modulate the behavioral processes related to ethanol con-
sumption, dependence, abuse, and addiction.
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